Markets:

Overview

News

Currencies

International

Treasuries

iShares U.S. Pharmaceutical ETF (NY:IHE)

100.74 -0.20 (-0.20%)

Streaming Delayed Price Updated: 1:45 PM EDT, Jul 22, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares U.S. Pharmaceutical ETF

< Previous 1 2 3 Next >

3 Sector ETFs That Beat The Market Last Week ↗

August 14, 2023

Here are three ETFs from different sectors that were in green last week.

Via Talk Markets

Topics ETFs

Pharma ETFs in Focus Post Q2 Earnings ↗

August 11, 2023

Second-quarter earnings for the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 30.7% on 5% revenue growth.

Via Talk Markets

Topics ETFs

3 Biotech Stocks to Sell in June Before They Crash and Burn ↗

June 06, 2023

Investors should get out of these biotech stocks to sell now that the Covid-19 pandemic is largely over. These's worse in store for them.

Via InvestorPlace

Pharma ETFs Gain Post Q1 Earnings ↗

May 09, 2023

Pharma ETFs have been in the green over the past month.

Via Talk Markets

A Look At Pharma ETFs Post Q4 Earnings ↗

February 08, 2023

Many industry bigwigs reported solid results, with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.

Via Talk Markets

US Pharmaceuticals: A Bifurcated Market ↗

January 12, 2022

The US pharmaceutical industry faces two important goals that conflict with each other.

Via Talk Markets

4 Sector ETFs To Watch Ahead Of Mid-Election Results ↗

November 10, 2022

Some market analysts are signaling that a political gridlock by Republicans may be a positive for Wall Street and the U.S. economy.

Via Talk Markets

5 ETFs To Watch After 2022 Midterm Elections: Which Sectors Win From Republican Or Democrat Majority? ↗

November 09, 2022

The 2022 election was held on Tuesday, Nov. 8. No decision has been made as to who won many of the key battles, including several pivotal seats in the U.S. House of Representatives and U.S. Senate.

Via Benzinga

Pharma ETFs In Focus Post Q3 Earnings ↗

November 09, 2022

Many industry bigwigs reported solid results with some beating on earnings or revenues or both. However, solid earnings failed to fully impress pharma ETFs over the past month.

Via Talk Markets

ETF Mid-Year Outlook & Investing Strategies ↗

July 22, 2022

While positioning the portfolio for the second half investors should focus on three themes: 1) embracing volatility, 2) living with inflation, and 3) the long-term impacts of shortages.

Via Talk Markets

Wave of Solid Q3 Earnings Push Pharma ETFs Higher ↗

November 09, 2021

The slew of Q3 results has led to smooth trading in pharma ETFs over the past month.

Via Talk Markets

J&J ETFs to Gain on Upbeat COVID-19 Vaccine Data ↗

September 25, 2021

Johnson & Johnson has again announced positive data highlighting the efficiency of its single-shot COVID-19 vaccine in providing protection against COVID-related hospitalizations.

Via Talk Markets

Will Pfizer ETFs Soar on FDA's COVID-19 Vaccine Booster Approval? ↗

September 24, 2021

Investors have one more reason to cheer the COVID-19 vaccine update as the FDA has approved emergency use of a booster dose of the Pfizer Inc. and BioNTech SE COVID-19 vaccine.

Via Talk Markets

3 Dividend-Paying Pharmaceutical Stocks to Buy This Summer ↗

June 05, 2021

The pharmaceutical industry has benefited from much investor attention amid the COVID-19 pandemic.

Via Talk Markets

Tuesday Talk: Slip Sliding Sideways ↗

May 18, 2021

With the Middle East seemingly going to Hell in a proverbial handbasket the markets seem to be slip sliding, not away (as the Paul Simon song would have it) sideways as it were.

Via Talk Markets

5 Sector ETFs That Survived Last Week's Turmoil ↗

May 17, 2021

Here are five sector ETFs that performed well last week and survived the broad market rout.

Via Talk Markets

Pharma ETFs in Focus Post Q1 Earnings ↗

May 12, 2021

The slew of Q1 results has led to mixed trading in pharma ETFs over the past month. Here are those in detail.

Via Talk Markets

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.